GUARNIERI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 16.300
AS - Asia 6.161
EU - Europa 5.926
SA - Sud America 604
Continente sconosciuto - Info sul continente non disponibili 549
AF - Africa 164
OC - Oceania 27
Totale 29.731
Nazione #
US - Stati Uniti d'America 16.060
SG - Singapore 2.303
CN - Cina 1.594
IT - Italia 1.000
SE - Svezia 963
UA - Ucraina 839
PL - Polonia 576
VN - Vietnam 563
HK - Hong Kong 541
DE - Germania 527
BR - Brasile 447
FI - Finlandia 408
FR - Francia 363
KR - Corea 319
GB - Regno Unito 304
RU - Federazione Russa 248
TR - Turchia 236
BD - Bangladesh 191
BG - Bulgaria 146
IE - Irlanda 145
CA - Canada 131
NL - Olanda 128
IN - India 120
CH - Svizzera 71
JP - Giappone 63
AR - Argentina 62
MA - Marocco 53
BE - Belgio 52
MX - Messico 50
SN - Senegal 31
ZA - Sudafrica 26
ES - Italia 25
CO - Colombia 24
AU - Australia 21
IQ - Iraq 21
SA - Arabia Saudita 21
TH - Thailandia 21
RS - Serbia 20
PK - Pakistan 19
EC - Ecuador 18
PH - Filippine 18
VE - Venezuela 18
ID - Indonesia 17
AE - Emirati Arabi Uniti 15
LT - Lituania 14
AT - Austria 13
EG - Egitto 13
EU - Europa 13
JO - Giordania 12
TW - Taiwan 12
IL - Israele 11
RO - Romania 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
DK - Danimarca 10
TT - Trinidad e Tobago 10
AZ - Azerbaigian 9
CR - Costa Rica 9
KE - Kenya 9
MY - Malesia 9
CL - Cile 8
HN - Honduras 8
PE - Perù 8
A2 - ???statistics.table.value.countryCode.A2??? 7
JM - Giamaica 7
PY - Paraguay 7
OM - Oman 6
PT - Portogallo 6
SV - El Salvador 6
UY - Uruguay 6
NG - Nigeria 5
SI - Slovenia 5
TN - Tunisia 5
AL - Albania 4
DZ - Algeria 4
EE - Estonia 4
IR - Iran 4
KZ - Kazakistan 4
LV - Lettonia 4
MK - Macedonia 4
MP - Marianne Settentrionali, isole 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MT - Malta 3
AO - Angola 2
BF - Burkina Faso 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
Totale 29.162
Città #
Woodbridge 1.676
Ashburn 1.528
Fairfield 1.526
Singapore 1.391
Ann Arbor 1.338
Houston 1.308
Chandler 942
Jacksonville 750
Wilmington 709
San Jose 698
Seattle 629
Hong Kong 527
Cambridge 513
Warsaw 430
Hefei 399
Beijing 357
Seoul 305
Princeton 273
Boardman 262
Columbus 221
Council Bluffs 217
Los Angeles 194
Chicago 190
Trieste 190
Izmir 187
Ho Chi Minh City 163
Hanoi 148
Dublin 146
Sofia 143
Santa Clara 141
Milan 133
Lauterbourg 131
Zgierz 128
Helsinki 127
The Dalles 112
Dearborn 111
Frankfurt am Main 101
Moscow 101
Buffalo 100
Dallas 96
San Diego 78
New York 74
Düsseldorf 73
Munich 71
Bern 57
Grafing 57
São Paulo 52
Brussels 49
Des Moines 48
London 48
Casablanca 46
Verona 46
Tokyo 45
Atlanta 43
Phoenix 42
Montreal 35
Turku 33
Washington 33
Falls Church 32
Da Nang 31
Dakar 31
Bremen 30
Guangzhou 30
Nanjing 29
Chennai 28
Kunming 27
Shanghai 27
Shenyang 27
Brooklyn 26
Orem 26
Tianjin 26
Toronto 26
Ottawa 25
Denver 24
Mestre 24
Auburn Hills 23
Norwalk 22
Jinan 21
Memphis 20
Redondo Beach 20
Rio de Janeiro 20
San Francisco 20
Belgrade 19
Rome 19
Haiphong 18
Stockholm 18
Boston 17
Amsterdam 16
Nuremberg 16
Pune 16
Bangkok 15
Johannesburg 15
Venice 15
Ankara 14
Hải Dương 14
Charlotte 13
Fremont 13
Istanbul 13
Miano 13
Zhengzhou 13
Totale 20.463
Nome #
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 537
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 415
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals 356
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 338
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 329
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 326
Acylated Ghrelin Limits Fat Accumulation and Improves Redox State and Inflammation Markers in the Liver of High-Fat-Fed Rats. 316
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 316
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 310
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 305
Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion. 300
Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. 291
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 285
D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. A 2-year follow-up. 284
Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment 282
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 272
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 271
Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile 269
Amino acid and protein therapy in chronic renal failure. 263
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. 262
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 261
Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. 260
Nutrition in Renal Disease 259
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 257
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 256
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers 254
Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients. 253
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. 252
Whey protein ingestion enhances postprandial anabolism during short-term bed rest in young men. 251
Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3 243
Metabolic response to injury and sepsis: changes in protein metabolism. 238
MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. 233
Effects of growth hormone administration on skeletal muscle glutamine metabolism in severely traumatized patients: preliminary report. 226
Physical inactivity decreases whole body glutamine turnover independently from changes in proteolysis. 225
Time-dependent changes in plasma total, acylated and desacylated ghrelin after gastric by-pass 225
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 220
Mechanisms of malnutrition in uremia. 219
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 217
Carnitine metabolism in uremia 213
n-3-Pufa Dietary Enrichment Improves Whole-Body Insulin Action and Normalizes Muscle Mass, Mitochondrial Function, Oxidative Stress, and Insulin Signalling in Experimental Uremia 211
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. 209
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 207
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 204
Slower activation of insulin action in hypertension associated with obesity. 202
Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients. 202
Modulation of protein kinetics in chronic renal failure. 202
MMP-9 microsatellite polymorphism and multiple sclerosis. 201
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 199
Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity. 198
Differential Cross-Sectional and Prospective Predictive Value for Insulin Resistance of Different Anthropometric Indexes and Parameters in A North-East Italy Community-Based Population Cohort 197
Effects of L-carnitine supplementation in the dialysate on serum lipoprotein composition of hemodialysis patients. 196
Sensitivity of whole body protein synthesis to amino acid administration during short-term bed rest. 196
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. 194
Rheological and mechanical properties of pluronic-alginate gels for drug-eluting stent coating 193
Antibiotics and renal tubular damage in cirrhosis. 190
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. 190
Intravenous lipid infusion and total plasma fatty acids positively modulate plasma acylated ghrelin in vivo 187
Evaluation of dietary compliance in patients with chronic renal failure on conservative treatment: comparison of methods to assess dietary intake 181
Molecular regulation of protein catabolism in trauma patients. 180
Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. 178
Potential applications of small interferring RNA in the cardiovascular field 177
Charactherization of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 176
The Kidney 175
Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. 173
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 172
Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction 172
Rheological properties of aqueous Pluronic-alginate systems containing liposomes 172
The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index – Results from the North-East Italy MoMa Population Study 170
High plasma retinol binding protein 4 (RBP4) is associated with systemic inflammation independently of low RBP4 adipose expression and is normalized by transplantation in nonobese, nondiabetic patients with chronic kidney disease 169
Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases 168
Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis 167
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 167
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 167
Clinical Nutrition 163
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 162
Nutritional assessment in patients with early renal insufficiency on long-term low protein diet. 159
Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia 159
Nutritional and metabolic effects of ten years of protein-restricted diet in patients with early renal failure 158
Slower activation of insulin action in upper body obesity. 158
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 158
Effects of erythropoietin administration on nutritional state and erythrocyte metabolism in maintenance hemodialysis patients. 157
Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. 157
Calorie restriction accelerates the catabolism of lean body mass during 2 wk of bed rest. 157
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 156
Metabolic syndrome and chronic kidney disease. 156
null 155
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 155
Role of E2F1–Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAs 153
Advances in carnitine in chronic uremia 152
null 152
Simple methods for nutritional assessment in hemodialyzed patients 151
Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats 151
Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. 150
Unacylated Ghrelin: A Novel Regulator of Muscle Intermediate Metabolism With Potential Beneficial Effects in Chronic Kidney Disease 148
Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rat. 147
Muscle cathepsin D activity, and RNA, DNA and protein content in maintenance hemodialysis patients. 146
The kidney 146
Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile 146
Caloric restriction improves endothelial dysfunction during vascular aging: Effects on nitric oxide synthase isoforms and oxidative stress in rat aorta. 143
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 140
Totale 21.366
Categoria #
all - tutte 85.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.589 0 0 60 186 64 190 69 52 187 190 181 410
2022/20232.607 233 336 201 393 238 476 7 223 316 20 135 29
2023/20241.354 151 104 93 83 141 119 253 168 12 35 109 86
2024/20253.022 46 80 212 286 313 299 215 155 399 375 285 357
2025/20267.625 727 402 535 633 703 766 1.229 221 788 985 321 315
2026/2027888 188 431 269 0 0 0 0 0 0 0 0 0
Totale 29.731